Exercise for Menopause Anxiety and Mood: What Actually Helps

Yes, exercise meaningfully reduces anxiety and low mood in perimenopausal and menopausal women, with effect sizes in the moderate range and benefit visible within 4-8 weeks. The 2018 JAMA Psychiatry meta-analysis by Gordon and colleagues pooled 33 trials and found resistance training produced a moderate effect on depressive symptoms (standardised mean difference -0.66) regardless of baseline depression status [14]. The Schuch 2016 meta-analysis on aerobic exercise and depression found similarly large effects when adjusting for publication bias [5]. The Stubbs 2017 review on exercise and anxiety disorders documented anxiolytic effects across resistance and aerobic modalities [6]. Exercise is not a substitute for clinical treatment when depression or anxiety is severe, but it is one of the most reliably effective adjunctive interventions available to women in this life stage.

At a glance: what helps menopausal anxiety and mood

Intervention	Evidence strength	How long it takes	Practical take
Resistance training, 2-3x/week	Moderate-to-large (Gordon 2018 meta-analysis [14])	4-8 weeks	Strongest single intervention for low mood in this population.
Aerobic exercise, 3-5x/week	Moderate (Schuch 2016 [5], Cooney 2013 Cochrane [7])	6-12 weeks	Works at moderate intensity. Walking counts.
Yoga, 2-3x/week	Modest (Newton 2014 [4], Carmody 2011 [10])	8-12 weeks	Useful adjunct, particularly for vasomotor-driven anxiety.
Pilates, 2-3x/week	Promising (Aibar-Almazán 2019 [3])	8-12 weeks	Improves anxiety and depression scores in postmenopausal women.
HIIT, 1-2x/week, kept short	Mixed	Variable	Useful for mood when not overdone. Daily HIIT often makes anxiety worse.
Mindfulness combined with exercise	Modest	8 weeks	Carmody 2011 MBSR trial reduced hot-flash bother and improved sleep [10].
Daily walking outdoors	Modest standalone, large as foundation	2-4 weeks	Light exposure plus movement plus reduced rumination.
Severe over-training	Worsens mood (Hackney 2006 [11])	n/a	The classic perimenopause trap. Cortisol stays elevated, mood worsens.

Why menopause increases anxiety and low mood in the first place

Three overlapping mechanisms explain the rise in anxiety and low mood across the menopausal transition: oestrogen withdrawal affects serotonin and dopamine signalling, sleep disruption from vasomotor symptoms degrades emotional regulation, and the cumulative life-stress load of midlife adds to the underlying biology. Bromberger and Kravitz, summarising the SWAN cohort data in 2011, documented that perimenopausal women have roughly two to four times the risk of new-onset depressive symptoms compared to premenopausal women, with the highest risk concentrated in the late perimenopausal transition [8].

The oestrogen pathway is the most direct. Oestrogen receptors are present in the brain regions that regulate mood (prefrontal cortex, amygdala, hippocampus) and oestrogen has known effects on serotonin synthesis, dopamine signalling, and HPA-axis regulation. When oestrogen declines, these systems lose modulation. Maki and colleagues, writing the 2018 clinical practice guideline on perimenopausal depression, made the case that perimenopausal depression is biologically distinct from depression at other life stages and often responds differently to standard treatments [9].

The sleep pathway compounds the biology. Vasomotor symptoms (hot flashes, night sweats) wake women repeatedly through the second half of the night. Chronic sleep restriction degrades emotional regulation, increases anxious arousal, and reduces the cognitive resources needed to manage everyday stress. Spiegel and colleagues established the leptin-ghrelin-mood-cortisol cascade from sleep restriction in their 2004 Annals of Internal Medicine paper, and the same mechanism applies to the fragmented sleep typical of perimenopause.

The third pathway is psychosocial. Many women hit perimenopause at the same time as ageing parents, teenage children, peak career demand, and the cumulative weight of two or three decades of carrying multiple roles. The biology lowers the threshold at which the load becomes overwhelming. The same stressors that were manageable at 35 can produce a different response at 47, and this is not weakness or character failure. It is a measurable change in how the nervous system handles input.

Why does this matter for an exercise guide? Because exercise is one of the very few interventions that touches all three mechanisms at once. It modifies neurotransmitter availability and receptor sensitivity. It improves sleep architecture (covered in detail in the menopause insomnia guide). It reduces the cortisol response to everyday stressors. None of these are placebo effects; they are documented in controlled trials.

Why exercise actually helps menopausal anxiety and mood

Exercise improves menopausal mood through four pathways: neurotransmitter modulation, HPA-axis recalibration, improved sleep, and self-efficacy gains. The Schuch 2016 meta-analysis adjusting for publication bias found exercise produced a large antidepressant effect (SMD -1.11) in adults with depression, comparable to first-line pharmacotherapy in head-to-head trials [5]. The Cooney 2013 Cochrane review found smaller but still significant effects across 39 trials [7]. The exact mechanisms are still being characterised but the directional evidence is unambiguous.

The neurotransmitter pathway works through several channels. Acute exercise increases brain availability of serotonin, dopamine, noradrenaline and brain-derived neurotrophic factor (BDNF). Chronic training upregulates the receptor sensitivity for these signals. The cumulative effect is similar in direction to what SSRIs and SNRIs produce pharmacologically, with a different mechanism and without the side-effect profile.

The HPA-axis pathway matters specifically in perimenopause. Hackney’s 2006 review in Expert Review of Endocrinology and Metabolism documented that older adults produce a larger cortisol response to acute stressors, with the effect amplified by reduced sex-hormone-mediated cortisol buffering after menopause [11]. Regular moderate exercise blunts this response over time. The trainee’s nervous system becomes less reactive to daily stressors, which is the underlying mechanism behind the “I feel calmer overall” effect that women in this age range describe after 6-8 weeks of consistent training.

The sleep pathway is the silent driver of the mood effect. Better sleep means better emotional regulation the following day. Better emotional regulation means smaller anxious responses to everyday stressors. Smaller anxious responses mean lower evening cortisol. Lower evening cortisol means easier sleep onset. The loop runs in the right direction once exercise establishes it, and exercise is the most reliable way to start it.

The self-efficacy pathway is often dismissed as soft but it is real and measurable. Trainees who successfully complete a structured 12-week strength programme score higher on mastery scales and lower on perceived helplessness. For women navigating a period of biological change that often feels out of control, the experience of measurable progress (a heavier squat, a longer walk, a session that felt impossible six weeks ago) restores agency in a way few other interventions match.

Strength training and mood

Resistance training is the highest-evidence single exercise intervention for low mood in women over 40, with the 2018 JAMA Psychiatry meta-analysis by Gordon and colleagues documenting a standardised mean difference of -0.66 on depressive symptoms across 33 trials. The effect was independent of baseline depression status, training volume, and significant strength gains, suggesting the mood effect is not contingent on the trainee becoming visibly stronger [14]. The benefit applies whether someone has clinical depression or sub-clinical low mood.

Singh and colleagues at the University of Sydney ran one of the strongest single trials in this space in 2005, randomising older adults with clinical depression to high-intensity resistance training, low-intensity resistance training, or general practitioner care. The high-intensity group showed remission rates of 33% after 8 weeks, comparable to standard pharmacotherapy outcomes [13]. The trial established that older adults can tolerate genuinely heavy strength training and that the antidepressant effect responds to dose.

What does this look like practically for a woman in perimenopause with low mood? Two to three sessions a week, full-body or upper/lower split, working through compound movements (squat, hinge, push, pull, carry) at weights that make the last 2-3 reps of each set feel hard. Sessions of 35-50 minutes including warm-up. Progressive overload built in (when 12 reps feel manageable, the weight goes up). The dose is the same as for body composition or bone density. The mood effect emerges as a side effect of the same training.

Programmes that map onto this pattern include Caroline Girvan CGX (7.7 overall, 6 for Women Over 40), Burn360 (8.3 overall) for shorter sessions, and Evlo ([?] overall) for women whose previous high-intensity programmes left them depleted rather than energised. The structural feature that matters is progressive overload with adequate recovery, not the brand.

Aerobic exercise and mood

Moderate aerobic exercise produces a large antidepressant effect (Schuch 2016 SMD -1.11) and a moderate anxiolytic effect (Stubbs 2017), with the effect size dependent on consistency rather than on intensity. Walking at a brisk pace four to five days a week meets the threshold the trial literature has used for these effects. There is no evidence that running is required, and the cortisol-cost considerations covered in the walking guide argue for moderate over high intensity in this age range.

The Stubbs 2017 review in Psychiatry Research looked specifically at adults with diagnosed anxiety or stress-related disorders. The pooled effect size was moderate (Hedges’ g of around 0.58), with effects emerging within 8-12 weeks of consistent training [6]. The Stonerock 2015 systematic review in Annals of Behavioral Medicine reached similar conclusions across both anxious symptoms and clinical anxiety disorders [15]. The directional consistency across reviews is strong.

For perimenopausal women specifically, the Sternfeld MsFLASH trial in 2014 randomised midlife women to aerobic exercise or a control condition for 12 weeks. The exercise group showed improvements in mood and quality-of-life scores in addition to the modest sleep benefit covered elsewhere [2]. Daley and colleagues ran a Cochrane review in 2014 on exercise for vasomotor symptoms specifically, with secondary outcomes including mood, and found consistent if modest benefit across trials [1].

The dose that produces these effects sits at roughly 150 minutes of moderate aerobic activity per week, distributed across 3-5 sessions. This matches the WHO physical activity guidelines and the BMS recommendations for women in the menopausal transition. Walking counts. Cycling counts. Swimming counts. The dance and aerobics video work that dominated women’s home fitness for decades counts too, when done at moderate intensity for adequate duration.

Yoga, mindfulness and breathwork for menopausal anxiety

Yoga and mindfulness produce modest but real reductions in menopausal anxiety, with the strongest evidence concentrated in trials combining mindfulness training with movement. Newton and colleagues ran a 12-week yoga trial in 249 women with vasomotor symptoms, published in Menopause in 2014. The yoga arm showed improvements in mood, sleep quality, and insomnia severity scores, alongside modest reductions in vasomotor bother [4]. Carmody and colleagues at the University of Massachusetts Medical School ran a 2011 trial of mindfulness-based stress reduction (MBSR) in menopausal women with hot flashes. The MBSR group showed improvements in hot-flash bother (a different metric than frequency), perceived stress, sleep, and quality of life [10].

The mechanism is partly direct (parasympathetic activation, reduced sympathetic arousal, slowed breathing, improved interoceptive awareness) and partly indirect (yoga and mindfulness practice tend to be done in environments that are calmer, more structured, and more body-aware than typical daily life). The practice itself is a contained period of low arousal, which over time recalibrates the trainee’s baseline.

For women whose primary symptom is anxious arousal rather than low mood, an evening yoga or breathwork session is often the most valuable single addition to a training week. A 20-30 minute slow yin or restorative yoga practice before bed slows the nervous system, lowers evening cortisol, and improves sleep onset latency. Box breathing (four-second inhale, four-second hold, four-second exhale, four-second hold) for five to ten minutes produces measurable reductions in heart rate variability markers of stress.

Programmes that fit this brief include The Sculpt Society (8.6) for Pilates-leaning low-impact work, and Pvolve (8.6) for resistance-band-based work that stays well below the cortisol-spike threshold. Neither is a substitute for the strength foundation, but as a complement they are useful.

HIIT and mood: the cortisol balance

Short HIIT sessions (1-2 per week, 15-25 minutes) generally improve mood; daily or near-daily HIIT often makes anxiety worse in perimenopausal women through chronic cortisol elevation. The dose is the variable that determines whether HIIT helps or hurts mood in this age range. The literature is consistent that acute HIIT produces a transient mood lift; the chronic mood effects depend entirely on whether weekly volume sits within the trainee’s recovery capacity.

Hackney’s 2006 review documented that the cortisol response to high-intensity exercise is larger in older adults than in younger adults [11]. In perimenopausal women specifically, where the buffering effect of oestrogen on cortisol response is reduced, the same HIIT session that produced a mood lift at 35 can produce a delayed mood crash at 50 if the recovery infrastructure isn’t there. The practical implication is that HIIT remains a useful tool but the dose has to drop.

What works in practice: one or two HIIT sessions a week, capped at 25 minutes including warm-up, done before late evening. The HIIT for perimenopause guide covers the dose mathematics in detail. What doesn’t work in this population: five days of moderate-to-hard HIIT, daily Peloton classes, bootcamp formats prescribing four to six high-intensity sessions a week. The cortisol bill comes due, and in perimenopausal women that bill often shows up as worsening anxiety, sleep disruption, and mood instability rather than as obvious physical fatigue.

The pattern most likely to flip HIIT from helpful to harmful: doing it daily, doing it within 60-90 minutes of bedtime, doing it without strength training as a foundation, and pairing it with severe caloric restriction. Avoid those four and HIIT continues to be useful. Combine them and the mood and anxiety picture worsens reliably.

The dose that produces mood and anxiety benefits

The dose that consistently produces mood and anxiety benefits in the trial literature is 150 minutes of moderate-intensity activity per week plus 2-3 strength sessions, distributed across 4-5 active days with 2-3 genuine rest days. This dose meets the WHO and NHS physical activity guidelines and matches the volumes used in most positive exercise-and-mood trials including Schuch 2016, Stubbs 2017, and Gordon 2018 [5][6][14].

The intensity question is the one most often misunderstood. The literature is consistent that moderate intensity is enough for mood benefit. Brisk walking, cycling at conversational pace, gentle hiking, swimming at steady effort. Vigorous intensity adds little incremental mood benefit and adds significant cortisol cost in this age range. The Singh 2005 high-intensity strength training trial showed that strength can be high-intensity without a mood penalty (the cortisol kinetics of strength training differ from cardio), but the cardio component should sit mostly in Zone 2 [13].

Frequency matters more than session length for mood specifically. A 30-minute walk five days a week produces stronger mood effects than a 90-minute session twice a week, even though the total weekly time is similar. The likely mechanism is that mood regulation responds to frequent, distributed cues rather than to occasional large doses. This is the same pattern observed in pharmacological treatment of mood disorders, where consistent daily dosing outperforms variable weekly dosing.

Consistency over weeks is the variable that most affects whether the dose works. The trial literature consistently measures mood outcomes at 8-12 weeks. Trainees who stop at week 4 because nothing has obviously changed cut themselves off two to four weeks before the largest benefits typically arrive. Twelve weeks is the minimum useful test period for any exercise intervention targeting mood.

How long until exercise actually improves your mood

Expect the first mood improvements within 2-4 weeks, with the largest gains typically arriving at 6-12 weeks of consistent training. This timeline matches the trial literature: Singh 2005 measured at 8 weeks, Sternfeld MsFLASH measured at 12 weeks, Gordon 2018 meta-analysis pooled trials of 4-78 weeks with median 12 weeks [13][2][14]. The first improvements are usually subtle (slightly more stable mood across the day, less reactive to small stressors) and the larger improvements compound over months.

The progression is usually predictable. Weeks 1-2 are mostly nervous-system adaptation to the training and establishment of routine; mood may dip slightly as the body adjusts to the new demand, particularly if sleep is disrupted. Weeks 3-6 bring the first noticeable mood and energy improvements alongside early strength gains. Weeks 6-12 are usually when the new mood baseline becomes obvious to the trainee and to people around her. Months 4-12 bring continued consolidation rather than dramatic further gains.

Reasonable benchmarks to track over 12 weeks:

• Daily mood rating: simple 1-10 scale at the same time each day. Look for the weekly average to trend up.
• Anxious episode frequency: count of moments of acute anxiety per week. Should decrease.
• Sleep quality: subjective 1-10 score on waking. Closely tied to mood.
• Reactivity to small stressors: the household, work or family irritations that used to derail the day for an hour. Should derail for less time as training accumulates.

Don’t expect linear progression. Mood follows a fluctuating trend even on a working intervention. A bad week in week 4 is not evidence the intervention isn’t working. The trend across rolling 4-week averages is the metric that matters, not any single day’s rating.

When exercise isn’t enough: clinical depression flags, HRT and therapy

Exercise alone isn’t enough when the underlying issue is clinical depression, severe perimenopausal anxiety disorder, or hormonal change that exceeds what behavioural intervention can offset. The Maki 2018 clinical practice guideline on perimenopausal depression listed CBT, antidepressants (with attention to perimenopause-specific response patterns), HRT in women with concurrent vasomotor symptoms, and psychotherapy as evidence-based options alongside exercise [9]. Exercise is part of the picture; it is not the whole picture for severe presentations.

Red flags worth raising with a GP rather than trying to exercise through:

• Persistent low mood for more than two weeks that doesn’t lift with normal life events.
• Loss of interest in activities previously enjoyed, including the exercise itself.
• Significant changes in appetite or sleep beyond what would be expected from menopause.
• Persistent feelings of hopelessness, worthlessness, or guilt.
• Recurrent thoughts of self-harm or suicide, in which case immediate help is the priority. In the UK, the Samaritans (116 123) is open 24/7. In the US, 988 is the Suicide and Crisis Lifeline.
• Anxiety severe enough to limit daily activities (avoiding situations, panic attacks, persistent physical symptoms of anxiety).

HRT is the elephant in the menopause-mood room. The Maki 2018 guideline lists HRT as a reasonable consideration for perimenopausal women with concurrent vasomotor symptoms and depressive symptoms, with the strongest evidence in early perimenopause [9]. HRT is not a treatment for depression in postmenopausal women without vasomotor symptoms. The British Menopause Society and The Menopause Society both publish guidance on the symptom profiles where HRT is appropriate.

CBT (cognitive behavioural therapy) has strong evidence for both depression and anxiety in midlife women, with delivery available through NHS Talking Therapies in the UK and via private and insurance-funded providers internationally. CBT pairs particularly well with exercise: the two interventions address different mechanisms and the combination outperforms either alone in head-to-head trials. If exercise on its own isn’t moving the needle after 12 weeks, CBT is the next step worth taking before or alongside antidepressant medication.

A sample week for menopausal anxiety and mood

Here’s a 7-day template combining the strongest evidence-backed interventions for menopausal mood: 3 strength sessions, 1-2 walks for steady-state cardio, 1 yoga or restorative session, 2 genuine rest days. Adjust intensity to your fitness baseline. If you’ve been sedentary, start with the walking and add one strength session a week, then build over six weeks.

Day	Main session	Notes
Monday	Strength: full-body, 40 min	Compound lifts, 3-4 sets, RPE 7-8. Mood lift within 30-60 min.
Tuesday	Brisk walk outdoors, 30-45 min, morning if possible	Light exposure for circadian + mood benefit.
Wednesday	Strength: full-body or upper/lower, 40 min	Add 1-2 carry or core finishers.
Thursday	Yoga or restorative Pilates, 30 min, evening	Slow style. Doubles as wind-down.
Friday	Strength: full-body, 40 min	Optional 5-10 min Z2 finisher.
Saturday	Long walk, 60-90 min	Social, outdoors, no metrics. The mental health session.
Sunday	Rest or gentle mobility	Genuinely rest. Recovery is part of the dose.

Why this structure? Three strength sessions hit the dose Gordon 2018 supports for the mood effect [14]. The walking quota covers the Schuch 2016 aerobic benefit [5] and adds light exposure for circadian and mood support. The yoga session covers the Newton 2014 and Carmody 2011 mindfulness benefits [4][10]. Two genuine recovery days protect against the cortisol over-training pattern that worsens mood in this age range. If only four sessions are possible, drop one strength session. If only three, keep two strength and the long Saturday walk.

Programmes that fit menopausal mood support

The programmes that work best for menopausal mood support share three features: structured progressive strength as the foundation, recovery built into the weekly schedule, and intensity options that don’t push trainees into chronic over-training. Below are the platforms reviewed at herdailyfit.com/programs that fit this brief.

Caroline Girvan CGX (7.7 overall, 6 for Women Over 40, 7.5 for Recovery). Heavy compound strength, four sessions a week, 45-50 minutes. Maps directly onto the Gordon 2018 resistance training protocol [14]. Full review at the CGX programme page.

Burn360 (8.3 overall). Compound dumbbell strength in 20-25 minute sessions with linear progression. Best fit for women with limited training time who want strength results without 50-minute sessions. Full review at the Burn360 programme page.

Evlo ([?] overall). DPT-designed strength training with explicit lower-cortisol programming and built-in deload weeks. Best for women whose previous high-intensity programmes left them depleted rather than progressed, which is a common entry point for women with anxiety symptoms. Full review at the Evlo programme page.

The Sculpt Society (8.6 overall, 9 for Joint Friendliness). Pilates-leaning, lower-load, easy on joints. Pairs well as the wind-down complement to a heavier strength foundation. Full review at the Sculpt Society programme page.

Pvolve (8.6 overall). Resistance-band-based, low-impact, with structured progressions. Good fit for women returning to exercise after a long gap, particularly when anxiety symptoms have made gym environments feel overwhelming. Full review at the Pvolve programme page.

Avoid programmes that demand 6+ days a week of moderate-to-hard work, regardless of how the marketing frames it. The cortisol cost in perimenopausal women with anxiety symptoms is too high. Match the dose to the recovery available, not to the calendar.

Common mistakes that worsen anxiety and mood

Five training patterns reliably worsen anxiety and mood in perimenopausal women: chronic over-training, daily HIIT without recovery, training through severe under-fuelling, late-evening intensive sessions, and abandoning a programme at week 4. Each one has a fix, and each one is more common than the wellness messaging acknowledges.

Over-training shows up as five or six days a week of moderate-to-hard sessions with no genuine rest. Heart rate stays slightly elevated, sleep quality drops, mood becomes edgy and reactive, anxiety symptoms intensify. The fix is two scheduled rest days a week and a deliberate intensity drop on at least one strength day.

Daily HIIT without recovery infrastructure compounds the over-training problem. The cortisol cost of repeated maximal-effort sessions exceeds the recovery available, baseline cortisol rises, and mood follows. The fix is capping HIIT at 1-2 sessions a week with 72+ hours between sessions.

Training through severe under-fuelling, particularly low carbohydrate intake on training days, raises evening cortisol and worsens mood and sleep. The fix is matching intake to output, even if scale weight stalls. The Trexler 2014 metabolic adaptation review documented this pattern in athletes; the menopausal hormonal context only amplifies it.

Late-evening intensive sessions within 90 minutes of bedtime fragment sleep, which degrades the next day’s emotional regulation. The fix is moving hard sessions earlier in the day, or substituting light walks or restorative practice for evening slots.

Abandoning a programme at week 4 is the silent killer of mood-focused training. The trial literature consistently measures mood outcomes at 8-12 weeks. Stopping at four weeks because nothing has obviously changed cuts the trainee off two to four weeks before the largest benefits typically arrive. Twelve weeks is the minimum useful test.

When exercise initially feels worse for anxiety: the first 2-3 weeks

Some women with significant baseline anxiety find that exercise initially amplifies anxious symptoms in the first 2-3 weeks before the longer-term anxiolytic effect emerges. The acute physiological response to training (elevated heart rate, increased breathing rate, sweating) overlaps with the somatic symptoms of anxiety, and the body’s interoceptive system can interpret the training response as anxiety. This is well-documented in the anxiety-and-exercise literature and resolves with continued training over weeks.

The mechanism is partly conditioned and partly cognitive. Anxious bodies often attend more closely to internal sensations (heart rate, breathing changes), which means exercise sensations register more intensely than they would for less anxious people. The brain can interpret these sensations as anxiety building rather than as appropriate response to physical effort. Stubbs and colleagues addressed this directly in their 2017 review, noting that initial discomfort doesn’t predict poor long-term response and that gradual exposure typically reduces the perceived overlap [6].

The practical fix: start gentler than feels necessary. Walking and light yoga in the first 2 weeks before progressing to higher-intensity training. Gradual ramp of strength training intensity rather than starting at full effort. Awareness that the first session of higher-intensity work may feel harder than expected, and that the discomfort doesn’t mean the intervention is wrong. Women who push through this initial period almost always emerge with the broader mood and anxiety benefits documented in the trial literature.

For women whose anxiety is significant enough that exercise initially feels overwhelming, working with a women’s health physiotherapist or qualified coach for the first few weeks often helps. The structure and accountability address the cognitive interpretation of physical sensations and build confidence alongside capacity.

Exercise compared to antidepressants and HRT for perimenopausal mood

For mild-to-moderate perimenopausal mood symptoms, exercise produces effects comparable to first-line antidepressant medication in head-to-head trials. For severe symptoms, exercise works alongside medication rather than replacing it. HRT specifically addresses mood symptoms when those symptoms are linked to vasomotor disruption or oestrogen withdrawal. The Cooney 2013 Cochrane review on exercise for depression compared exercise to psychological and pharmacological treatments across multiple trials and found the modalities produced broadly similar effect sizes for mild-to-moderate depression [7].

The clinical hierarchy for perimenopausal mood symptoms looks roughly like this. Mild mood symptoms often respond to lifestyle interventions: exercise, sleep optimisation, stress management, social connection, and addressing modifiable contributors (caffeine, alcohol, life stress load). Moderate symptoms typically warrant adding CBT or other structured psychotherapy, with HRT consideration if vasomotor symptoms are present. Severe symptoms (or symptoms with significant functional impairment, or any thoughts of self-harm) warrant medical management with antidepressant medication and specialist mental health input alongside the lifestyle interventions.

The exercise-and-antidepressant relationship matters because many women receive antidepressant prescriptions for perimenopausal mood symptoms that may have responded better to HRT or to a combination of HRT plus exercise plus CBT. Maki and colleagues’ 2018 clinical practice guideline on perimenopausal depression specifically addressed this, recommending HRT consideration as part of the treatment toolkit for women with concurrent vasomotor symptoms, alongside CBT and antidepressants where indicated [9]. The decision is individual and warrants a menopause-informed clinician rather than a generic prescription.

For women already on antidepressant medication, exercise produces additional benefit on top of the medication effect. Multiple trials have documented that exercise combined with antidepressants outperforms antidepressants alone for symptom remission and relapse prevention. The mechanisms are complementary: medication adjusts neurotransmitter balance pharmacologically, exercise produces neurotransmitter and structural brain changes through physiological pathways, and the combination addresses different aspects of the same underlying condition.

The practical implication is that the “exercise instead of medication” framing common in popular wellness messaging is often the wrong question. The right framing is “exercise as part of the treatment picture,” with the rest of the picture (CBT, HRT, medication, sleep, social support) included as appropriate to symptom severity and individual circumstances. Women whose perimenopausal mood symptoms are significantly affecting their lives benefit from full assessment rather than from trying to fix the issue through training intensification alone.

Where the evidence is still evolving

Three areas of the menopause-mood-exercise literature are still genuinely under-studied: the optimal exercise dose for perimenopausal anxiety specifically, the interaction between HRT and exercise on mood outcomes, and whether different exercise modalities produce meaningfully different mood effects in this population.

The dose question is the biggest gap. Most positive trials use 3-5 sessions a week of moderate-to-vigorous exercise. Whether 2 sessions captures most of the benefit, or whether 5 sessions adds materially more, has not been mapped with precision in perimenopausal women specifically. The pragmatic answer is 3-4 sessions, but this is informed opinion rather than settled finding.

The HRT-exercise interaction is interesting but under-studied. HRT improves mood in women with concurrent vasomotor symptoms (Maki 2018 [9]), and exercise improves mood across most populations (Schuch 2016 [5], Gordon 2018 [14]). Whether their effects are additive, redundant, or synergistic in perimenopausal women has not been studied directly in head-to-head trials. Anecdotally, women on HRT seem to respond at least as well to exercise as women without; the mechanisms suggest the effects should be additive, but this is a hypothesis rather than a finding.

The modality question (strength vs aerobic vs yoga vs HIIT) has reasonable comparative data in mixed adult populations but limited menopause-specific head-to-head trials. The Gordon 2018 meta-analysis suggests resistance training has at least as strong a mood effect as aerobic exercise, with perhaps a slight edge [14], but this needs replication in perimenopause-specific trial designs.

Glossary

BDNF (brain-derived neurotrophic factor): a protein that supports neuron survival and growth. Increased acutely by exercise. Implicated in mood regulation.

CBT (cognitive behavioural therapy): structured psychotherapy for depression, anxiety, and other conditions. First-line non-pharmacological treatment per most clinical guidelines.

HPA axis: hypothalamic-pituitary-adrenal axis. The cortisol regulation system. Disrupted in chronic stress and during the menopausal transition.

MBSR: mindfulness-based stress reduction. A structured 8-week mindfulness training programme with substantial evidence in stress, anxiety and chronic illness contexts.

Perimenopausal depression: depressive symptoms emerging during the menopausal transition, often distinct in presentation and treatment response from depression at other life stages.

SMD (standardised mean difference): a meta-analytic measure of effect size. Roughly 0.2 = small, 0.5 = moderate, 0.8 = large.

SSRI: selective serotonin reuptake inhibitor. A class of antidepressant medication including sertraline, citalopram and fluoxetine.

SWAN: Study of Women’s Health Across the Nation. Long-running US cohort study tracking women through the menopausal transition.

Vasomotor symptoms (VMS): hot flashes and night sweats. Often associated with sleep disruption and mood effects.

References

1. Daley A, Stokes-Lampard H, Thomas A, MacArthur C. Exercise for vasomotor menopausal symptoms. Cochrane Database Syst Rev. 2014;(11):CD006108. PubMed: 25431132
2. Sternfeld B, Guthrie KA, Ensrud KE, et al. Efficacy of exercise for menopausal symptoms: a randomized controlled trial. Menopause. 2014;21(4):330-338. PubMed: 23899828
3. Aibar-Almazán A, Hita-Contreras F, Cruz-Díaz D, et al. Effects of Pilates training on sleep quality, anxiety, depression and fatigue in postmenopausal women. Maturitas. 2019;124:62-67. PubMed: 31097181
4. Newton KM, Reed SD, Guthrie KA, et al. Efficacy of yoga for vasomotor symptoms: a randomized controlled trial. Menopause. 2014;21(4):339-346. PubMed: 24045673
5. Schuch FB, Vancampfort D, Richards J, Rosenbaum S, Ward PB, Stubbs B. Exercise as a treatment for depression: A meta-analysis adjusting for publication bias. J Psychiatr Res. 2016;77:42-51. PubMed: 26978184
6. Stubbs B, Vancampfort D, Rosenbaum S, et al. An examination of the anxiolytic effects of exercise for people with anxiety and stress-related disorders: a meta-analysis. Psychiatry Res. 2017;249:102-108. PubMed: 28092779
7. Cooney GM, Dwan K, Greig CA, et al. Exercise for depression. Cochrane Database Syst Rev. 2013;(9):CD004366. PubMed: 24026850
8. Bromberger JT, Kravitz HM. Mood and menopause: findings from the Study of Women’s Health Across the Nation (SWAN) over 10 years. Obstet Gynecol Clin North Am. 2011;38(3):609-625. PubMed: 21961723
9. Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. J Womens Health (Larchmt). 2019;28(2):117-134. PubMed: 30182804
10. Carmody JF, Crawford S, Salmoirago-Blotcher E, et al. Mindfulness training for coping with hot flashes: results of a randomized trial. Menopause. 2011;18(6):611-620. PubMed: 21372745
11. Hackney AC. Stress and the neuroendocrine system: the role of exercise as a stressor and modifier of stress. Expert Rev Endocrinol Metab. 2006;1(6):783-792. PubMed: 16645310
12. Kandola A, Vancampfort D, Herring M, et al. Moving to beat anxiety: epidemiology and therapeutic issues with physical activity for anxiety. Curr Psychiatry Rep. 2018;20(8):63. PubMed: 30043270
13. Singh NA, Stavrinos TM, Scarbek Y, et al. A randomized controlled trial of high versus low intensity weight training versus general practitioner care for clinical depression in older adults. J Gerontol A Biol Sci Med Sci. 2005;60(6):768-776. PubMed: 15983181
14. Gordon BR, McDowell CP, Hallgren M, et al. Association of efficacy of resistance exercise training with depressive symptoms: meta-analysis and meta-regression. JAMA Psychiatry. 2018;75(6):566-576. PubMed: 29800984
15. Stonerock GL, Hoffman BM, Smith PJ, Blumenthal JA. Exercise as treatment for anxiety: systematic review and analysis. Ann Behav Med. 2015;49(4):542-556. PubMed: 25697132
16. British Menopause Society. Tools for clinicians: mood and the menopause. Available at: thebms.org.uk
17. NHS. Menopause symptoms and treatments. Available at: nhs.uk/conditions/menopause/symptoms
18. The Menopause Society. Mood changes at menopause. Available at: menopause.org
19. Trexler ET, Smith-Ryan AE, Norton LE. Metabolic adaptation to weight loss: implications for the athlete. J Int Soc Sports Nutr. 2014;11:7. PubMed: 24571926

Frequently Asked Questions